These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24372239)

  • 1. Endothelial cell targeted molecular imaging in tumor angiogenesis: strategies and current status.
    Xu Y; Zeng Y; Liu Y; Liu G; Ai H
    Curr Pharm Biotechnol; 2013; 14(7):644-57. PubMed ID: 24372239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles.
    Wang J; Qin B; Chen X; Wagner WR; Villanueva FS
    Mol Pharm; 2017 Mar; 14(3):781-790. PubMed ID: 28165246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality molecular imaging of tumor angiogenesis.
    Cai W; Chen X
    J Nucl Med; 2008 Jun; 49 Suppl 2():113S-28S. PubMed ID: 18523069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological mechanisms of angiogenesis.
    Walsh DA
    Adv Clin Chem; 2007; 44():187-221. PubMed ID: 17682343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.
    Wang Y; Wang L; Chen C; Chu X
    Mol Cancer; 2018 Feb; 17(1):22. PubMed ID: 29415727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence.
    Wang R; Zhang K; Tao H; Du W; Wang D; Huang Z; Zhou M; Xu Y; Wang Y; Liu N; Wang H; Li Z
    Curr Pharm Biotechnol; 2017; 18(5):422-428. PubMed ID: 28545358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
    Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
    Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular ultrasound assessment of tumor angiogenesis.
    Deshpande N; Pysz MA; Willmann JK
    Angiogenesis; 2010 Jun; 13(2):175-88. PubMed ID: 20549555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted in vivo imaging of angiogenesis: present status and perspectives.
    Choe YS; Lee KH
    Curr Pharm Des; 2007; 13(1):17-31. PubMed ID: 17266586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical molecular imaging of tumor angiogenesis.
    Zhu L; Niu G; Fang X; Chen X
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):291-308. PubMed ID: 20639815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging tumor angiogenesis.
    Red-Horse K; Ferrara N
    J Clin Invest; 2006 Oct; 116(10):2585-7. PubMed ID: 17016553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond.
    Mittal K; Ebos J; Rini B
    Semin Oncol; 2014 Apr; 41(2):235-51. PubMed ID: 24787295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
    Sato Y
    Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets.
    Vizán P; Sánchez-Tena S; Alcarraz-Vizán G; Soler M; Messeguer R; Pujol MD; Lee WN; Cascante M
    Carcinogenesis; 2009 Jun; 30(6):946-52. PubMed ID: 19369582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled small molecule inhibitors of VEGFR - recent advances.
    Kniess T
    Curr Pharm Des; 2012; 18(20):2867-74. PubMed ID: 22571655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective.
    Missiaen R; Morales-Rodriguez F; Eelen G; Carmeliet P
    Vascul Pharmacol; 2017 Mar; 90():8-18. PubMed ID: 28082117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis.
    Lin KT; Lien JC; Chung CH; Kuo SC; Huang TF
    Eur J Pharmacol; 2010 Mar; 630(1-3):53-60. PubMed ID: 20067787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. αV integrins in angiogenesis and cancer.
    Weis SM; Cheresh DA
    Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a006478. PubMed ID: 22229119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
    Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
    Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.